June 15, 2023
by Andrii Buvailo
Interview
We're fortunate to speak with Dr. James Field, founder and CEO of LabGenius, a leading machine learning (ML)-driven protein engineering …
April 18, 2023
by Andrii Buvailo
Interview
With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer …
March 14, 2023
by Andrii Buvailo
Interview
In this interview, we speak with Mark Andrews, Investment Director, Life Sciences, Funds at British Patient Capital, the largest domestic …
March 1, 2023
by Andrii Buvailo
Interview
Recently, David Dowling, a senior lawyer at Ropes & Gray, has outlined his predictions for M&A in the European biotech …
Jan. 17, 2023
by Sabina Lee
Interview
Sponsored by Syntekabio
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
Dec. 28, 2022
by Andrii Buvailo
Interview
The aging research industry has exploded in recent years. Once a fringe area of science, aging research has now gained …
Dec. 22, 2022
by Andrii Buvailo
Interview
The medical device industry is driven by constant innovation, and the annual Medica conference offers the chance to discover the …
Nov. 6, 2022
by Andrii Buvailo
Interview
While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker …
Oct. 14, 2022
by Andrii Buvailo
Interview
In contrast to molecular mechanics, which describes molecules as essentially “balls and sticks” kind of objects, taking into account only …
Aug. 17, 2022
by Andrii Buvailo
Interview
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase …
Aug. 15, 2022
by Andrii Buvailo
Interview
Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a …
June 8, 2022
by Andrii Buvailo
Interview
Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment …